Lillehoj (USDA) and Collett (UGA) to Speak on Antibiotic Alternatives and Intestinal Health at Upcoming Seminar Hosted by Amlan International
CHICAGO, IL.—Two of the recognized experts in the areas of the avian microbiome and the role bacteria play in the pathogenesis of disease, Dr. Hyun Lillehoj of the USDA and Stephen Collett from the University of Georgia, will be featured speakers at a technical seminar held on Wednesday, January 27th, 2016 at 10am at the Omni Atlanta Hotel at CNN Center, in downtown Atlanta, Georgia. Organized by animal health company Amlan International, this invitation‐only event is sure to spark discussion in light of the industry’s growing focus on the role of antibiotics.
Lillehoj, a 20 year veteran of the Agricultural Research Service (ARS) of the USDA at the Beltsville Agricultural Research Center, will be speaking about using dietary immunomodulation as a means to reduce the effects of enteric disease. Lillihoj is an international authority on avian health and has conducted considerable research on reducing the need for antibiotics to control enteric diseases.
Stephen R. Collett, a Clinical Associate Professor at the Poultry Diagnostic and Research Center (PDRC) in the College of Veterinary Medicine at The University of Georgia, will be speaking on dysbacteriosis and the role bacterial toxins play in disease. As a collaborative researcher at the PDRC, Collett focuses on managing the health of the digestive tract to maximize bird welfare, nutrient assimilation and performance.
“As a company focused on providing natural disease management solutions, we are thrilled to have the opportunity to learn from and collaborate with two of the greatest minds in the industry,” said Dr. Ron Cravens, President, Amlan International.
Following the two 1‐hour sessions, Amlan International will host a lunch reception to preview its new product, Varium, a new formulated feed additive that promotes broiler growth equivalent to antibiotics by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.
About Amlan International
A wholly owned subsidiary of the Oil‐Dri Corporation of America (NYSE: ODC), Amlan International helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP‐alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.
Share this post: